CLINICAL_TRIALS
trial_result
· 2026-03-05
Clinical Trial Update: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression [Phase 2]
Summary
A Phase 2 completed trial update evaluating maintenance ketamine infusions for treatment-resistant bipolar depression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joshua Rosenblat | Conditions: Bipolar Disorder, Bipolar Depression | Phase 2 | Status: COMPLETED